Logo image of ISOS

ISOS ACQUISITION CORP-A (ISOS) Stock Fundamental Analysis

NYSE:ISOS - New York Stock Exchange, Inc. - Common Stock

10  +0.2 (+2.04%)

After market: 10.05 +0.05 (+0.5%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ISOS. ISOS was compared to 0 industry peers in the Unkown industry. The financial health of ISOS is average, but there are quite some concerns on its profitability. ISOS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ISOS has reported negative net income.
ISOS Yearly Net Income VS EBIT VS OCF VS FCFISOS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 -2K -4K -6K -8K

1.2 Ratios

Industry RankSector Rank
ROA 0%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ISOS Yearly ROA, ROE, ROICISOS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 -10 -20 -30 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ISOS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ISOS Yearly Profit, Operating, Gross MarginsISOS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020

More info and screens

6

2. Health

2.1 Basic Checks

ISOS Yearly Shares OutstandingISOS Yearly Shares OutstandingYearly Shares Outstanding 2020 5M 10M 15M 20M
ISOS Yearly Total Debt VS Total AssetsISOS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 10K 20K 30K 40K

2.2 Solvency

ISOS has an Altman-Z score of 5.70. This indicates that ISOS is financially healthy and has little risk of bankruptcy at the moment.
ISOS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.7
ROIC/WACCN/A
WACCN/A
ISOS Yearly LT Debt VS Equity VS FCFISOS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 5K 10K 15K

2.3 Liquidity

ISOS has a Current Ratio of 6.40. This indicates that ISOS is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 6.40 indicates that ISOS has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 6.4
Quick Ratio 6.4
ISOS Yearly Current Assets VS Current LiabilitesISOS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 10K 20K 30K 40K

More info and screens

1

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 269.23% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2Y5961.35%
EPS Next 3Y973.98%
EPS Next 5Y269.23%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ISOS Yearly Revenue VS EstimatesISOS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
ISOS Yearly EPS VS EstimatesISOS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2022 2023 2024 2025 2026 0.5 1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
ISOS Price Earnings VS Forward Price EarningsISOS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ISOS Per share dataISOS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as ISOS's earnings are expected to grow with 973.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5961.35%
EPS Next 3Y973.98%

More info and screens

0

5. Dividend

5.1 Amount

ISOS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ISOS ACQUISITION CORP-A

NYSE:ISOS (12/15/2021, 8:35:59 PM)

After market: 10.05 +0.05 (+0.5%)

10

+0.2 (+2.04%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners53.59%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap318.55M
Analysts82.5
Price Target13.94 (39.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.42
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS7.02
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y1%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score0
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.4
Quick Ratio 6.4
Altman-Z 5.7
F-Score0
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2Y5961.35%
EPS Next 3Y973.98%
EPS Next 5Y269.23%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A